NTRA Natera, Inc.
Nasdaq · SEC CIK 1604821 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $376.04M 134 sales by 12 insiders
- Filings on record
- 782 since 2021-07-07, latest 2026-09-18 21:35
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Rabinowitz Matthew | EXECUTIVE COB, Dir | — | $124.05M |
| Chapman Steven Leonard | CEO AND Pres, Dir | — | $93.95M |
| BOTHA ROELOF | Dir | — | $34.89M |
| RABINOWITZ DANIEL | SEC. AND CLO | — | $23.83M |
| Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | — | $22.88M |
| Sheena Jonathan | Dir, CO-FOUNDER | — | $22.83M |
| Brophy Michael Burkes | CFO | — | $22.14M |
| ROSENMAN HERM | Dir | — | $15.14M |
| Fesko John | Pres, CHIEF BUS. Off | — | $9.35M |
| Baynes Roy D. | Dir | — | $2.81M |
Transactions 1,058
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-18 21:35 | 2026-09-16 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | G - Gift | $0.00 | -945 | 109.9K | -0.9% | $0 | |
| MT | 2026-09-17 21:35 | 2026-09-15+ | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $351.49 | -9,150 | 221.3K | -4% | -$3.22M |
| MT | 2026-09-16 21:35 | 2026-09-14+ | NTRA | Rabinowitz Matthew | EXECUTIVE COB, Dir | S - Sale | $340.97 | -100.0K | 2.13M | -4% | -$34.10M |
| TI | 2026-09-16 21:35 | 2026-09-15 | NTRA | Rabinowitz Matthew | EXECUTIVE COB, Dir | S - Sale | $350.01 | -2,000 | 0 | -100% | -$700.0K |
| MT | 2026-09-11 21:35 | 2026-09-11 | NTRA | Rabinowitz Matthew | EXECUTIVE COB, Dir | S - Sale | $327.97 | -50.0K | 2.23M | -2% | -$16.40M |
| MT | 2026-09-03 21:35 | 2026-09-01+ | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $325.88 | -18.2K | 110.9K | -14% | -$5.92M |
| T | 2026-09-03 21:05 | 2026-09-01 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale | $320.99 | -1,698 | 98.2K | -2% | -$545.0K |
| T | 2026-08-28 21:35 | 2026-08-06 | NTRA | Fesko John | Pres, CHIEF BUS. Off | A - Grant | $0.00 | +20.0K | 203.8K | +11% | $0 |
| T | 2026-08-28 21:35 | 2026-08-10 | NTRA | Fesko John | Pres, CHIEF BUS. Off | S - Sale | $321.53 | -6,517 | 197.3K | -3% | -$2.10M |
| T | 2026-08-14 21:35 | 2026-08-10 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $325.32 | -6,000 | 230.5K | -3% | -$1.95M |
| TI | 2026-08-07 21:35 | 2026-08-07 | NTRA | Rabinowitz Matthew | EXECUTIVE COB, Dir | S - Sale | $320.90 | -2,000 | 2,000 | -50% | -$641.8K |
| MT | 2026-08-07 21:35 | 2026-08-07 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $315.66 | -9,150 | 236.5K | -4% | -$2.89M |
| MT | 2026-08-05 21:35 | 2026-08-03+ | NTRA | Brophy Michael Burkes | CFO | S - Sale | $271.74 | -795 | 51.6K | -2% | -$216.0K |
| MT | 2026-08-05 21:35 | 2026-08-03 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale | $266.39 | -3,076 | 99.9K | -3% | -$819.4K |
| T | 2026-08-05 21:35 | 2026-08-03 | NTRA | Fesko John | Pres, CHIEF BUS. Off | S - Sale | $267.99 | -295 | 183.8K | -0.2% | -$79.1K |
| MT | 2026-08-05 21:35 | 2026-08-03 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $265.58 | -3,410 | 129.0K | -3% | -$905.6K |
| T | 2026-08-05 21:35 | 2026-08-03 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | S - Sale | $267.99 | -334 | 170.1K | -0.2% | -$89.5K |
| T | 2026-08-05 21:35 | 2026-08-03 | NTRA | Rabinowitz Matthew | EXECUTIVE COB, Dir | S - Sale | $267.99 | -731 | 2.28M | -0.0% | -$195.9K |
| T | 2026-08-05 21:35 | 2026-08-03 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $267.99 | -109 | 245.6K | -0.0% | -$29.2K |
| MT | 2026-07-29 21:35 | 2026-07-27+ | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $257.93 | -479 | 245.7K | -0.2% | -$123.5K |
| T | 2026-07-29 21:35 | 2026-07-27 | NTRA | Rabinowitz Matthew | EXECUTIVE COB, Dir | S - Sale | $260.49 | -1,718 | 2.28M | -0.1% | -$447.5K |
| MT | 2026-07-29 21:35 | 2026-07-27+ | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | S - Sale | $257.08 | -1,887 | 170.4K | -1% | -$485.1K |
| MT | 2026-07-29 21:35 | 2026-07-27+ | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $257.00 | -2,214 | 132.4K | -2% | -$569.0K |
| MT | 2026-07-29 21:35 | 2026-07-27+ | NTRA | Fesko John | Pres, CHIEF BUS. Off | S - Sale | $257.00 | -1,713 | 184.1K | -0.9% | -$440.2K |
| MT | 2026-07-29 21:35 | 2026-07-27+ | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale | $256.51 | -5,770 | 103.0K | -5% | -$1.48M |
| MT | 2026-07-29 21:35 | 2026-07-27+ | NTRA | Brophy Michael Burkes | CFO | S - Sale | $253.28 | -5,064 | 52.4K | -9% | -$1.28M |
| MTI | 2026-07-17 21:05 | 2026-07-15 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $273.88 | -1,500 | 18.0K | -8% | -$410.8K |
| T | 2026-07-17 21:05 | 2026-07-15 | NTRA | Chapman Rowan E | Dir | S - Sale | $274.82 | -135 | 4,663 | -3% | -$37.1K |
| MT | 2026-07-15 21:05 | 2026-07-13 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $265.68 | -3,150 | 246.2K | -1% | -$836.9K |
| TI | 2026-07-08 21:05 | 2026-07-06 | NTRA | Rabinowitz Matthew | EXECUTIVE COB, Dir | S - Sale | $280.00 | -1,000 | 4,000 | -20% | -$280.0K |
| MT | 2026-07-06 21:05 | 2026-07-01 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | S - Sale | $272.29 | -16.8K | 172.3K | -9% | -$4.57M |
| MT | 2026-07-06 21:05 | 2026-07-01 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $272.90 | -3,000 | 134.6K | -2% | -$818.7K |
| 2026-06-30 20:05 | 2026-06-26 | NTRA | Rubin Eric H | Dir | A - Grant | — | +75 | 2,204 | +4% | — | |
| M | 2026-06-30 20:05 | 2026-06-26 | NTRA | ROSENMAN HERM | Dir | A - Grant | — | +1,677 | 5,927 | +39% | — |
| M | 2026-06-30 20:05 | 2026-06-26 | NTRA | Marcus Gail Boxer | Dir | A - Grant | — | +1,669 | 7,852 | +27% | — |
| 2026-06-30 20:05 | 2026-06-26 | NTRA | Lynch Thomas J. Jr. | Dir | A - Grant | — | +1,905 | 1,905 | New | — | |
| M | 2026-06-30 20:05 | 2026-06-26 | NTRA | Chapman Rowan E | Dir | A - Grant | — | +1,674 | 4,798 | +54% | — |
| M | 2026-06-30 20:05 | 2026-06-26 | NTRA | BOTHA ROELOF | Dir | A - Grant | — | +1,691 | 4,585 | +58% | — |
| M | 2026-06-30 20:05 | 2026-06-26 | NTRA | Bertagnolli Monica | Dir | A - Grant | — | +1,646 | 7,020 | +31% | — |
| M | 2026-06-30 20:05 | 2026-06-26 | NTRA | Baynes Roy D. | Dir | A - Grant | — | +1,646 | 20.2K | +9% | — |
| MT | 2026-06-26 21:05 | 2026-06-24 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | S - Sale | $251.65 | -33.6K | 189.1K | -15% | -$8.46M |
| T | 2026-06-26 21:05 | 2026-06-24 | NTRA | ROSENMAN HERM | Dir | S - Sale | $250.00 | -16.5K | 4,250 | -80% | -$4.13M |
| MTI | 2026-06-22 21:05 | 2026-06-17 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $219.87 | -1,500 | 18.8K | -7% | -$329.8K |
| T | 2026-06-17 21:05 | 2026-06-16 | NTRA | Chapman Rowan E | Dir | S - Sale | $216.78 | -2,964 | 3,124 | -49% | -$642.5K |
| MT | 2026-06-17 21:05 | 2026-06-15 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $211.14 | -3,150 | 249.4K | -1% | -$665.1K |
| MT | 2026-06-16 21:35 | 2026-06-12+ | NTRA | Rabinowitz Matthew | EXECUTIVE COB, Dir | S - Sale | $214.47 | -100.0K | 2.28M | -4% | -$21.45M |
| D | 2026-06-09 21:05 | 2026-06-05 | NTRA | Marcus Gail Boxer | Dir | M - OptEx | $22.83 | +11.0K | 17.2K | +178% | +$251.1K |
| DM | 2026-06-09 21:05 | 2026-06-05 | NTRA | Marcus Gail Boxer | Dir | S - Sale+OE | $217.21 | -11.0K | 6,183 | -64% | -$2.39M |
| MT | 2026-06-05 21:05 | 2026-06-04 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale | $221.03 | -41.1K | 108.7K | -27% | -$9.09M |
| MT | 2026-06-03 21:05 | 2026-06-01 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $218.43 | -3,000 | 137.6K | -2% | -$655.3K |
| 2026-06-03 21:05 | 2026-05-29 | NTRA | Rubin Eric H | Dir | A - Grant | — | +2,124 | 2,129 | +42,480% | — | |
| MI | 2026-06-03 16:40 | 2026-06-01 | NTRA | BOTHA ROELOF | Dir | S - Sale | $220.31 | -78.0K | 1.08M | -7% | -$17.18M |
| T | 2026-05-28 21:05 | 2026-05-26 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $202.84 | -1,652 | 140.6K | -1% | -$335.1K |
| T | 2026-05-28 21:05 | 2026-05-26 | NTRA | Fesko John | Pres, CHIEF BUS. Off | S - Sale | $202.84 | -1,438 | 185.8K | -0.8% | -$291.7K |
| MT | 2026-05-15 21:05 | 2026-05-08 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $208.60 | -3,150 | 252.5K | -1% | -$657.1K |
| MTI | 2026-05-15 21:05 | 2026-05-13 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $201.56 | -1,500 | 19.5K | -7% | -$302.3K |
| MT | 2026-05-06 21:35 | 2026-05-04+ | NTRA | Rabinowitz Matthew | EXECUTIVE COB, Dir | S - Sale | $213.05 | -7,708 | 2.38M | -0.3% | -$1.64M |
| T | 2026-05-06 21:35 | 2026-05-05 | NTRA | Rabinowitz Matthew | EXECUTIVE COB, Dir | A - Grant | — | +2,389 | 2.38M | +0.1% | — |
| MT | 2026-05-05 21:45 | 2026-05-01+ | NTRA | Brophy Michael Burkes | CFO | S - Sale | $208.79 | -795 | 57.5K | -1% | -$166.0K |
| T | 2026-05-05 21:35 | 2026-05-01 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $206.16 | -107 | 255.7K | -0.0% | -$22.1K |
| MT | 2026-05-05 21:35 | 2026-05-01 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $203.69 | -3,405 | 142.3K | -2% | -$693.6K |
| T | 2026-05-05 21:35 | 2026-05-01 | NTRA | Fesko John | Pres, CHIEF BUS. Off | S - Sale | $206.16 | -291 | 187.2K | -0.2% | -$60.0K |
| T | 2026-05-05 21:35 | 2026-05-01 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale | $206.16 | -902 | 149.9K | -0.6% | -$186.0K |
| T | 2026-05-05 21:35 | 2026-05-01 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | S - Sale | $206.16 | -330 | 222.7K | -0.1% | -$68.0K |
| MT | 2026-04-29 21:45 | 2026-04-27+ | NTRA | Brophy Michael Burkes | CFO | S - Sale | $197.84 | -5,063 | 58.3K | -8% | -$1.00M |
| MT | 2026-04-29 21:35 | 2026-04-27 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale | $204.14 | -5,838 | 150.8K | -4% | -$1.19M |
| MT | 2026-04-29 21:35 | 2026-04-27 | NTRA | Fesko John | Pres, CHIEF BUS. Off | S - Sale | $204.10 | -1,688 | 187.5K | -0.9% | -$344.5K |
| MT | 2026-04-29 21:35 | 2026-04-27 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $204.10 | -2,182 | 145.7K | -1% | -$445.3K |
| MT | 2026-04-29 21:35 | 2026-04-27 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | S - Sale | $204.09 | -1,861 | 223.0K | -0.8% | -$379.8K |
| MT | 2026-04-29 21:35 | 2026-04-27+ | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $197.43 | -3,544 | 255.7K | -1% | -$699.7K |
| M | 2026-04-28 20:35 | 2026-04-24 | NTRA | ROSENMAN HERM | Dir | A - Grant | — | +339 | 20.8K | +2% | — |
| M | 2026-04-28 20:35 | 2026-04-24 | NTRA | Marcus Gail Boxer | Dir | A - Grant | — | +330 | 6,183 | +6% | — |
| M | 2026-04-28 20:35 | 2026-04-24 | NTRA | Chapman Rowan E | Dir | A - Grant | — | +336 | 6,088 | +6% | — |
| M | 2026-04-28 20:35 | 2026-04-24 | NTRA | BOTHA ROELOF | Dir | A - Grant | — | +354 | 2,894 | +14% | — |
| 2026-04-28 20:35 | 2026-04-24 | NTRA | Rubin Eric H | Dir | A - Grant | — | +5 | 5 | New | — | |
| 2026-04-28 20:35 | 2026-04-24 | NTRA | Williams Brinkley Ruth | Dir | A - Grant | — | +86 | 5,475 | +2% | — | |
| 2026-04-28 20:35 | 2026-04-24 | NTRA | Bertagnolli Monica | Dir | A - Grant | — | +83 | 5,374 | +2% | — | |
| 2026-04-28 20:35 | 2026-04-24 | NTRA | Baynes Roy D. | Dir | A - Grant | — | +83 | 18.5K | +0.5% | — | |
| MTI | 2026-04-21 21:05 | 2026-04-17 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $199.63 | -1,500 | 20.3K | -7% | -$299.4K |
| D | 2026-04-08 21:05 | 2026-04-06 | NTRA | Rabinowitz Matthew | EXECUTIVE COB, Dir | M - OptEx | $9.59 | +58.3K | 2.41M | +2% | +$559.0K |
| D | 2026-04-08 21:05 | 2026-04-06 | NTRA | Rabinowitz Matthew | EXECUTIVE COB, Dir | F - Tax | $204.87 | -27.6K | 2.38M | -1% | -$5.66M |
| MT | 2026-04-03 21:05 | 2026-04-01 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | S - Sale | $203.31 | -8,400 | 224.9K | -4% | -$1.71M |
| MT | 2026-04-03 21:05 | 2026-04-01 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $202.30 | -3,000 | 147.9K | -2% | -$606.9K |
| D | 2026-04-01 21:05 | 2026-03-31 | NTRA | Rabinowitz Matthew | EXECUTIVE COB, Dir | M - OptEx | $9.59 | +41.7K | 2.35M | +2% | +$400.0K |
| M | 2026-03-20 | 2026-03-18 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $198.17 | -3,070 | 259.3K | -1% | -$608.4K |
| MI | 2026-03-20 | 2026-03-20 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $199.95 | -1,500 | 21.3K | -7% | -$299.9K |
| 2026-03-17 | 2026-03-13 | NTRA | Chapman Rowan E | Dir | S - Sale | $191.38 | -122 | 5,752 | -2% | -$23.3K | |
| DM | 2026-03-16 | 2026-03-12+ | NTRA | Rabinowitz Matthew | EXECUTIVE COB, Dir | S - Sale+OE | $191.42 | -200.0K | 2.31M | -8% | -$38.28M |
| DM | 2026-03-16 | 2026-03-12+ | NTRA | Rabinowitz Matthew | EXECUTIVE COB, Dir | M - OptEx | $9.59 | +200.0K | 2.39M | +9% | +$1.92M |
| 2026-03-11 | 2026-03-09 | NTRA | Fesko John | Pres, CHIEF BUS. Off | A - Grant | — | +1,774 | 189.9K | +0.9% | — | |
| 2026-03-11 | 2026-03-10 | NTRA | Fesko John | Pres, CHIEF BUS. Off | S - Sale | $204.13 | -707 | 189.2K | -0.4% | -$144.3K | |
| 2026-03-11 | 2026-03-10 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $204.13 | -127 | 262.3K | -0.0% | -$25.9K | |
| 2026-03-11 | 2026-03-09 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | A - Grant | — | +258 | 262.5K | +0.1% | — | |
| 2026-03-11 | 2026-03-10 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | S - Sale | $204.13 | -1,745 | 233.3K | -0.7% | -$356.2K | |
| 2026-03-11 | 2026-03-09 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | A - Grant | — | +1,745 | 235.0K | +0.7% | — | |
| 2026-03-11 | 2026-03-09 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | A - Grant | — | +5,623 | 162.2K | +4% | — | |
| 2026-03-11 | 2026-03-10 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale | $204.13 | -5,623 | 156.6K | -3% | -$1.15M | |
| 2026-03-11 | 2026-03-10 | NTRA | Brophy Michael Burkes | CFO | S - Sale | $204.13 | -785 | 63.4K | -1% | -$160.2K | |
| 2026-03-11 | 2026-03-09 | NTRA | Brophy Michael Burkes | CFO | A - Grant | — | +1,968 | 64.1K | +3% | — | |
| 2026-03-11 | 2026-03-10 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $204.13 | -915 | 150.9K | -0.6% | -$186.8K |
Purchase Sale Sale after option exercise All abbreviations